Indo Us Biotech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Indo US Biotech Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This compliance document confirms that the company's shares are properly dematerialized and eligible for electronic trading. It is a standard regulatory requirement for listed entities to maintain this certification to ensure smooth settlement of trades.

For investors, this development is a routine administrative update rather than a market-moving event. It confirms that the company's shareholding structure is in order and that shares can be transferred electronically without any regulatory hurdles. This ensures the integrity of the trading process for INDOUS shares.

Investors should note that this news does not indicate any new business activity or financial performance. The focus for the stock now remains on its underlying operational results and market conditions. Keeping an eye on the company's quarterly earnings will be more relevant for assessing its future price movement.